Skip to main content
Clinical Trials/IRCT20200426047206N2
IRCT20200426047206N2
Not yet recruiting
Phase 3

Clinical trial of efficacy and safety of mesenchymal stem cell transplantation in patients with COVID-19 pneumonia

Hamedan University of Medical Sciences0 sites30 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Hamedan University of Medical Sciences
Enrollment
30
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Positive PCR test
  • Age between 18\-70 years
  • patient with acute respiratory infectious symptoms and severe lung involvement

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials